Clinical Trial: SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06859775) titled 'SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer' on Feb. 27.

Brief Summary: This study is a multicentre, open-label, dose-finding/efficacy-expanding phase Ib/II clinical trial to evaluate the tolerability, safety, pharmacokinetic profile and immunogenicity of SHR-A1811 combination regimen in the treatment of recurrent or metastatic cervical cancer and to preliminarily evaluate the efficacy of SHR-A1811 combination regimen for recurrent or metastatic cervical cancer.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Recurrent or Metastatic Cervical Cancer

Intervention:...